Susquehanna International Group, LLP Brainstorm Cell Therapeutics Inc. Put Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	BUY	$0.34 - $0.74 $7,956 - $17,316	23,400 New	23,400 $7,000
Q4 2023 Feb 14, 2024	BUY	$0.15 - $0.4 $3,705 - $9,880	24,700 Added 100.41%	49,300 $13,000
Q3 2023 Nov 14, 2023	SELL	$0.2 - $2.08 $83,240 - $865,696	-416,200 Reduced 94.42%	24,600 $4,000
Q2 2023 Aug 11, 2023	BUY	$2.0 - $3.2 $463,400 - $741,440	231,700 Added 110.81%	440,800 $908,000
Q1 2023 May 16, 2023	BUY	$1.43 - $3.3 $273,130 - $630,300	191,000 Added 1055.25%	209,100 $690,000
Q4 2022 Feb 14, 2023	SELL	$1.37 - $4.42 $43,155 - $139,230	-31,500 Reduced 63.51%	18,100 $29,000
Q3 2022 Nov 14, 2022	SELL	$2.55 - $4.42 $84,660 - $146,744	-33,200 Reduced 40.1%	49,600 $219,000

12.3M

169K

30.6K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $8.03M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.